AMIDARONE-INDUCED HYPERTHYROIDISM: CARDIOLOGICAL ASPECTSO

dc.contributor.author	Abdikadirova Tursinay., Alieva Anna., Trigulova Raisa., Nasirova Khurshida
dc.date.accessioned	2026-09-16T10:24:49Z
dc.date.available	2026-09-16T10:24:49Z
dc.date.issued	2025-05-28
dc.identifier.issn	2394-3211
dc.identifier.uri	http://repo.tma.uz/xmlui/handle/1/5206
dc.description.abstract	Amiodarone-induced hyperthyroidism (AIH) is a serious complication in patients with arrhythmias undergoing long-term antiarrhythmic therapy. This article presents data from a retrospective observation of 16 patients with AIH who were hospitalized in the cardiology department. Hormonal parameters (TSH, free T4, T3, anti-TSH receptor antibodies) and cardiological indicators (heart rate, heart rate variability — SDNN) were analyzed before and after 6 months of antithyroid therapy. The results demonstrated a significant improvement in both hormonal and cardiac status, indicating the necessity of timely diagnosis and treatment of AIH. Particular attention is paid to the differential diagnosis of AIH types, treatment selection, and evaluation of effectiveness from the cardiologist's perspective.	en_US
dc.language.iso	en_US	en_US
dc.publisher	EUROPEAN JOURNAL OF PHARMACEUTICAL AND MEDICAL RESEARCH	en_US
dc.subject	Amiodarone, thyroid gland, Amiodarone-induced hyperthyroidism, Antiarrhythmic therapy, Heart rate variability.	en_US
dc.title	AMIDARONE-INDUCED HYPERTHYROIDISM: CARDIOLOGICAL ASPECTSO	en_US
dc.type	Article	en_US